41 results on '"Ashari, Luai H."'
Search Results
2. Supplementary Table S4 from TGFβ-induced SMAD4-dependent Apoptosis Proceeded by EMT in CRC
3. Supplementary Figure S1 from TGFβ-induced SMAD4-dependent Apoptosis Proceeded by EMT in CRC
4. Supplementary Materials and Methods from TGFβ-induced SMAD4-dependent Apoptosis Proceeded by EMT in CRC
5. Supplementary Figure 4 from Bortezomib (Velcade) Induces p27Kip1 Expression through S-Phase Kinase Protein 2 Degradation in Colorectal Cancer
6. Supplementary Figure 3 from Bortezomib (Velcade) Induces p27Kip1 Expression through S-Phase Kinase Protein 2 Degradation in Colorectal Cancer
7. Supplementary Figure 2 from Bortezomib (Velcade) Induces p27Kip1 Expression through S-Phase Kinase Protein 2 Degradation in Colorectal Cancer
8. Supplementary Figure Legends 1-4 from Bortezomib (Velcade) Induces p27Kip1 Expression through S-Phase Kinase Protein 2 Degradation in Colorectal Cancer
9. Supplementary Figure 1 from Bortezomib (Velcade) Induces p27Kip1 Expression through S-Phase Kinase Protein 2 Degradation in Colorectal Cancer
10. Expanding the spectrum of germline variants in cancer
11. Coexpression of Activated c-Met and Death Receptor 5 Predicts Better Survival in Colorectal Carcinoma
12. Bortezomib Stabilizes Mitotic Cyclins and Prevents Cell Cycle Progression via Inhibition of UBE2C in Colorectal Carcinoma
13. Functional Results of Laparoscopic Resection Rectopexy for Symptomatic Rectal Intussusception
14. Laparoscopically-Assisted Resection Rectopexy for Rectal Prolapse: Ten Years’ Experience
15. POLE and POLD1 germline exonuclease domain pathogenic variants, a rare event in colorectal cancer from the Middle East
16. Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication
17. Frequent PIK3CA gene amplification and its clinical significance in colorectal cancer
18. High Prevalence of Fatty Acid Synthase Expression in Colorectal Cancers in Middle Eastern Patients and Its Potential Role as a Therapeutic Target
19. Abstract 4286: TGFβ induced SMAD4 dependent apoptosis proceeded by EMT in colorectal cancer
20. TGFβ-induced SMAD4-dependent Apoptosis Proceeded by EMT in CRC
21. Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations
22. MED12is recurrently mutated in Middle Eastern colorectal cancer
23. Risk Factors for Abdominal Incision Infection after Colorectal Surgery in a Saudi Arabian Population: The Method of Surveillance Matters
24. Colorectal cancer in Saudi Arabia: incidence, survival, demographics and implications for national policies
25. MED12is recurrently mutated in Middle Eastern colorectal cancer
26. Clinico-pathological significance of TNF alpha-induced protein3 (TNFAIP3) in Middle Eastern colorectal carcinoma
27. Abstract 2104: Frequent inactivation of A20 and its prognostic significance in Middle Eastern colorectal carcinoma
28. Abstract 2980: Clinico-pathological correlation of UBE2C alterations in colorectal carcinoma and efficacy of UBE2C inhibition by proteosome inhibitor as a viable therapeutic target
29. Abstract 1069: Clinicopathological significance of CARD10 alterations in Middle Eastern colorectal cancer
30. Abstract 5482: c-Met and DR5 co-expression is an independent prognostic marker for better survival in colorectal carcinoma
31. Genome-Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1 as a Novel Target for Cancer Therapy
32. Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations
33. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B andKRASmutations in colorectal carcinoma
34. Bortezomib (Velcade) Induces p27Kip1 Expression through S-Phase Kinase Protein 2 Degradation in Colorectal Cancer
35. Detection of Metastatic Parathyroid Carcinoma With Tc-99m Sestamibi Imaging
36. Prognostic significance of TRAIL death receptorsin Middle Eastern colorectal carcinomas and theircorrelation to oncogenic KRAS alterations.
37. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
38. Bortezomib Stabilizes Mitotic Cyclins and Prevents Cell Cycle Progression via Inhibition of UBE2Cin Colorectal Carcinoma
39. Genome-Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1as a Novel Target for Cancer Therapy
40. MED12 is recurrently mutated in Middle Eastern colorectal cancer.
41. Colorectal carcinomas from Middle East. Molecular and tissue microarray analysis of genomic instability pathways.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.